1. Home
  2. PEB vs BHVN Comparison

PEB vs BHVN Comparison

Compare PEB & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

HOLD

Current Price

$18.33

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.90

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEB
BHVN
Founded
2009
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
PEB
BHVN
Price
$18.33
$15.90
Analyst Decision
Hold
Buy
Analyst Count
11
14
Target Price
$13.30
$29.08
AVG Volume (30 Days)
1.9M
2.5M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
0.28%
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
$1,475,544,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.53
N/A
52 Week Low
$9.99
$7.48
52 Week High
$19.93
$18.57

Technical Indicators

Market Signals
Indicator
PEB
BHVN
Relative Strength Index (RSI) 48.72 57.97
Support Level $18.35 $13.84
Resistance Level $19.73 $16.60
Average True Range (ATR) 0.48 1.08
MACD -0.00 0.21
Stochastic Oscillator 69.78 54.48

Price Performance

Historical Comparison
PEB
BHVN

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: